David L. Rick

Chlorpyrifos: Pharmacokinetics in human volunteers

R.J. Nolan, David L. Rick, N. L. Freshour et al. · Toxicology and Applied Pharmacology · 1984 · 448 citations

Pharmacy, Pharmacokinetics, Pharmacology +4

Assessment of diurnal systemic dose of agrochemicals in regulatory toxicity testing – An integrated approach without additional animal use

Shakil A. Saghir, Michael Bartels, David L. Rick et al. · Regulatory Toxicology and Pharmacology · 2012 · 56 citations

Pharmacy, Environmental Sciences, Toxicology +16

Reconstruction of Exposure to<i>m</i>-Xylene from Human Biomonitoring Data Using PBPK Modelling, Bayesian Inference, and Markov Chain Monte Carlo Simulation

Kevin McNally, Richard Cotton, John Cocker et al. · Journal of Toxicology · 2012 · 44 citations · Full text

Pharmacy, Pharmacokinetics, Toxicology +17

The Effect of Plasma Lipids on the Pharmacokinetics of Chlorpyrifos and the Impact on Interpretation of Blood Biomonitoring Data

Ezra R. Lowe, Torka S. Poet, David L. Rick et al. · Toxicological Sciences · 2009 · 43 citations · Full text

Life Sciences, Pharmacokinetics, Pharmacology +15

Development of a physiologically-based pharmacokinetic model of 2-phenoxyethanol and its metabolite phenoxyacetic acid in rats and humans to address toxicokinetic uncertainty in risk assessment

John Troutman, David L. Rick, Sharon B. Stuard et al. · Regulatory Toxicology and Pharmacology · 2015 · 38 citations

Pharmacy, Pharmacokinetics, Toxicology +15